Human Monoclonal Antibody AVP-21D9 to Protective Antigen Reduces Dissemination of the Bacillus anthracis Ames Strain from the Lungs in a Rabbit Model
- 1 July 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (7) , 3414-3424
- https://doi.org/10.1128/iai.00352-07
Abstract
Inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 (MSP119) are a significant component of inhibitory responses in individuals immune to malaria. Nevertheless, conflicting results have been obtained in determining whether this antibody specificity correlates with protection in residents of areas where malaria is endemic. In this study, we examined sera collected from a population of semi-immune individuals living in an area of Vietnam with meso-endemicity during a 6-month period. We used two Plasmodium falciparum parasite lines that express either endogenous MSP119 or the homologous region from Plasmodium yoelii to measure the MSP119-specific inhibitory activity. We showed that (i) the level of MSP119-specific inhibitory antibodies was not associated with a delay in P. falciparum infection, (ii) MSP119-specific inhibitory antibodies declined significantly during the convalescent period after infection, and (iii) there was no significant correlation between the MSP119-specific inhibitory antibodies and the total antibodies measured by enzyme-linked immunosorbent assay. These results have implications for understanding naturally acquired immunity to malaria and for the development and evaluation of MSP119-based vaccines.Keywords
This publication has 37 references indexed in Scilit:
- Toxin-Deficient Mutants of Bacillus anthracis Are Lethal in a Murine Model for Pulmonary AnthraxInfection and Immunity, 2006
- Protective Antigen as a Correlative Marker for Anthrax in Animal ModelsInfection and Immunity, 2006
- A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformationProceedings of the National Academy of Sciences, 2006
- Evaluation of the Protective Effects of Quinacrine AgainstBacillus anthracisAmesJournal of Toxicology and Environmental Health, Part A, 2006
- Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine☆Vaccine, 2006
- Immunological Correlates for Protection against Intranasal Challenge of Bacillus anthracis Spores Conferred by a Protective Antigen-Based Vaccine in RabbitsInfection and Immunity, 2006
- Direct Inhibition of T-Lymphocyte Activation by Anthrax Toxins In VivoInfection and Immunity, 2005
- Molecular basis for improved anthrax vaccinesAdvanced Drug Delivery Reviews, 2005
- Pathology and Pathogenesis of Bioterrorism-Related Inhalational AnthraxThe American Journal of Pathology, 2003
- Salmonella enterica Serovar Typhimurium Expressing a Chromosomally Integrated Copy of the Bacillus anthracis Protective Antigen Gene Protects Mice against an Anthrax Spore ChallengeInfection and Immunity, 2003